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Table 1 Gene-speci c forward and reverse primer sequences for real-time PCR.
Target mRNA Primer Sequence
18S rRNA
5 5'-GTAACCCGTTGAACCCCATT-3'
3' 5'-CCATCCAATCGGTAGTAGCG-3
KLF5
5' 5'-CATACACAATGCCAAGTCAG-3'
3' 5'-TAGAAGAAATTGTAGCAGCA-3'
MCP-1
5' 5'-TCTGTGCCTGCTGCTCATAG-3'
3' 5'-TGGAATCCTGAACCCACTTC-3'
3
Fig. 1 Separation of nuclear protein and cytoplasmic protein.
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Fig. 2 Inhibition of KLF5 mRNA by KLF5 siRNA.
 Compared with group C, the level of KLF5 mRNA was 
attenuated in group siK by KLF5 siRNA p<0.01 . 
Compared with group C, increase of the level of KLF5
mRNA after TNF-  stimulation was significantly higher 
in group T p<0.01 . This upregulation was attenuated 
in group TsiK by KLF5 siRNA compared with group T
p<0.05 .
4
71 114
C MCP-1 mRNA TNF-
T p<0.01, Fig. 4
T MCP-1 mRNA
KLF5 siRNA TsiK
p<0.05, Fig. 4
C MCP-1
TNF- T
p<0.05, Fig. 5 TNF- T
MCP-1 KLF5 siRNA
TsiK p<0.05, 
Fig. 5
MCP-1 TNF-
KLF5
3. KLF5 siRNA p50 p65
MCP-1 NF-
TNF- TNF-
KLF5 p50 p65
p50 p65
C TNF- T
p<0.01, Fig. 6a T p50
p65 KLF5 siRNA
TsiK p<0.01, Fig. 6a
p50 p65
C TNF- T
p<0.05, Fig. 6b
T p50 p65
KLF5 siRNA TsiK
Fig. 6b
TNF- NF- KLF5
NF- T TsiK
Fig. 3 Inhibition of the nuclear KLF5 protein level by KLF5
siRNA.
 Compared with group C, the nuclear KLF5 protein level 
was attenuated in group siK by KLF5 siRNA p<0.01 . 
There was signi cant increase of the nuclear KLF5 pro-
tein expression in group T, compared with group C
p<0.01 . TNF-  induced increase in KLF5 expression 
was significantly attenuated by KLF5 siRNA in group 
TsiK p<0.01 .
Fig. 4 Inhibition of MCP-1 mRNA by KLF5 siRNA.
 Compared with group C, the level of MCP-1 mRNA sig-
nificantly increased in group T by TNF-  stimulation
p<0.01 . This upregulation of MCP-1 mRNA in group 
T was attenuated in group TsiK by KLF5 siRNA p<0.05 .
Fig. 5 Inhibition of MCP-1 protein by KLF5 siRNA.
 Compared with group C, the level of MCP-1 protein in 
conditioned medium was greatly increased in group T by 
TNF-  stimulation p<0.05 . TNF- -induced increase 
in MCP-1 protein was significantly attenuated in group 
TsiK by KLF5 siRNA p<0.05 .
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Fig. 6a Inhibition of the nuclear p50 and p65 protein level by 
KLF5 siRNA.
 Compared with group C, the nuclear p50 and p65 protein 
levels were signi cantly increased by TNF-  stimulation 
in group T p<0.01 . However, the increases of 
nuclear p50 and p65 protein levels in group T were sig-
nificantly attenuated by KLF5 siRNA in group TsiK
p<0.01 .
Fig. 6b Cytoplasmic p50 and p65 protein levels.
 Compared with group C, cytoplasmic p50 and p65 pro-
tein levels were signi cantly increased by TNF-  stimu-
lation in group T p<0.05 . The increases of cytoplas-
mic p50 and p65 protein levels in group T were not 
attenuated by KLF5 siRNA in group TsiK.
Fig. 7 Inhibition of the pI  protein level by KLF5 siRNA.
 Compared with group C, pI  expression in cytoplasmic 
protein was increased by TNF-  stimulation in group T
p<0.05 . The increased pI  protein in group T was 
significantly attenuated by KLF5 siRNA in group TsiK
p<0.01 .
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Abstract
Objective : Endothelial cells are the rst barrier against stimulants such as tumor necrosis factor TNF -  or macrophage 
adhesion in the early initiation of atherosclerosis. One of the key molecules related to endothelial dysfunction is the in amma-
tory chemokine, monocyte chemoattractant protein MCP -1. Considering atherosclerosis in terms of risk factors, hyperten-
sion, dyslipidemia, hyperglycemia, metabolic syndrome and smoking are all pivotal and causing endothelial damage. We have 
already reported that MCP-1 expression is regulated by Krüppel-like factor KLF  5 in human umbilical vein endothelial cells 
HUVECs . Therefore, we hypothesized that KLF5 inhibition might reduce MCP-1 expression through regulation of nuclear 
factor-kappa NF-  signaling in endothelial cells. The purpose of this study was to examine whether KLF5 is associated 
with NF-  signaling and regulates MCP-1 expression.
Methods : HUVECs were divided into 4 groups : group C treated with control siRNA alone, group siK treated with KLF5
siRNA, group T treated with control siRNA and TNF- , and group TsiK treated with KLF5 siRNA and TNF- . Real-time PCR 
was carried out for MCP-1 mRNA. The protein level of phosphorylated inhibitor kappa pI  was measured by immu-
noblotting. MCP-1 protein, nuclear p50 and p65 protein levels were measured by ELISA.
Results : Compared with group C, the expressions of MCP-1 mRNA and MCP-1 protein signi cantly increased in group T 
p<0.05 . The upregulation of MCP-1 mRNA and MCP-1 protein in group T were attenuated in group TsiK by KLF5 siRNA 
p<0.05 . Compared with group C, the nuclear p50 and p65 protein level were significantly increased in group T 
p<0.01 . These increases of the nuclear p50 and p65 protein level in group T were signi cantly attenuated in group TsiK 
p<0.01 . Compared with group C, expression of pI in cytoplasmic protein was increased in group T p<0.05 . The 
increased pI  protein in group T was signi cantly attenuated in group TsiK p<0.01 .
Conclusion : KLF5 inhibition may reduce the MCP-1 expression through NF-  signal regulating in endothelial cells.
Key words :  Human umbilical vein endothelial cell HUVEC , Krüppel-like factor 5 KLF5 , Monocyte chemoattractant 
protein-1 MCP-1 , Nuclear factor-kappa NF- , Inhibitor kappa I .
